Home Arena Pharmaceuticals Announces BELVIQ (lorcaserin HCl) New Drug Submission In Canada
 

Keywords :   


Arena Pharmaceuticals Announces BELVIQ (lorcaserin HCl) New Drug Submission In Canada

2013-07-03 06:56:53| drugdiscoveryonline News Articles

Arena Pharmaceuticals, Inc.announced recently that Eisai Limited (based inMississauga, Ontario), a subsidiary of Eisai Inc., has submitted a New Drug Submission (NDS) for BELVIQ™ (lorcaserin HCl) with Health Canada

Tags: canada drug submission arena

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
23.11()PC-88015\"2D
23.11180&100m
23.11kenG
23.11ps3 CECH-4300C HDMI500
23.11 UNDERTALE PIANO SCORE
23.11MM6 BM11-SEC3 LC
23.11
23.11Blu-ray
More »